Amrize

Amrize was formed through the separation of Holcim’s North American businesses and is now an independent listed company focused on construction materials and solutions in the United States and Canada. Its activities range from cement, aggregates and concrete to roofing and building-envelope solutions, enabling it to participate in almost the entire construction cycle, ‘from foundation to rooftop’. With more than a thousand sites and facilities in North America, it is exposed to major structural trends such as infrastructure investment, residential and commercial construction, and the modernisation of real-estate assets.

After the original assessment, Chairman and CEO Jan Jenisch dramatically reinforced the insider thesis with around $1.27 million in purchases at approximately $42.47. This takes Insider Signal and Insider History to 10/10. However, the shares closed on 22 September at $39.00, 12.2% below the original opening reference, and both daily and monthly technicals deteriorated clearly. Valuation improved to around 14.5–15x forward P/E, but growth prospects remain moderate and analysts have issued downgrades. The CEO’s buying prevents a larger score decline but cannot offset the technical breakdown: 8.8.

After the initial cluster, Chairman and CEO Jan Jenisch added around $1.27 million in purchases at approximately $42.47.

A $44.44 reference price and a $39.00 close on 22 September: a 12.24% decline according to the document.

A profitable business, but with a still-short standalone trading history.

Growth prospects remain moderate; the rating falls from 8.4 to 8.0.

Forward P/E around 14.5–15x at the review.

A cluster involving the CFO, strategy, legal, marketing and directors, followed by additional CEO buying. Current rating: 10.0.

Additional CEO buying supports the insider thesis but does not remove operational and technical constraints.

A short standalone history, moderate prospects, analyst downgrades and a technical breakdown.

The daily chart was already trending down and has deteriorated; its rating falls from 6.9 to 4.7.

Clear monthly deterioration; the rating falls from 6.6 to 5.7.

AMRZ · NYSE in USD and SIX Swiss Exchange in CHF. Ordinary shares are dual listed. This research’s dollar reference corresponds to NYSE, without implicit conversion to the CHF listing.

Update: around $1.27 million of additional buying by the Chairman and CEO makes the insider signal even stronger, but a fall of more than 12% from the original reference, technical deterioration and moderate growth prospects leave AMRZ at 8.8/10.